Sarcoma trials in Colombia

4 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  Where

  Barranquilla, Bogota, D.C., Florindablanca, Medellín

  Age

  18 years and over

  People

  400 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07541170 · EU 2025-524263-21-01
• Phase 1/2Taking people
  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Where

  Barranquilla, Medellín, Montería

  Age

  6 months to 25 years

  People

  90 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06395103 · EU 2023-507178-41-00
• Phase 3Taking people
  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Where

  Bogota, Cali, Pereira, Valledupar

  Age

  18 years and over

  People

  348 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06345729 · EU 2023-507776-42-00
• No phaseTaking people
  International Rare Brain Tumor Registry

  Where

  Bogota, Bogotá

  Age

  Up to 45 years

  People

  5,800 worldwide

  Run by

  Children's National Research Institute

  See details and how to joinNCT05697874